Literature DB >> 17307348

Ikaros and chromatin regulation in early hematopoiesis.

Samuel Yao-Ming Ng1, Toshimi Yoshida, Katia Georgopoulos.   

Abstract

Hematopoiesis is the developmental process by which all blood and immune cells are generated. A decade-old scheme has supported an early and complete separation of the erythro-myeloid from the lymphoid lineages. Recent advances have re-drawn this map, separating lymphoid and myeloid from erythroid programs early in development. Subsequently, the fate restriction of both the lympho-myeloid and the erythro-megakaryocyte progenitors is dependent on Ikaros and its associated chromatin regulators. Genetic studies of this family of nuclear factors are now providing unique insight into the functional molecular signatures that bestow plasticity to the hematopoietic stem cell and its early progeny.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17307348     DOI: 10.1016/j.coi.2007.02.014

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  26 in total

1.  The human SWI/SNF complex associates with RUNX1 to control transcription of hematopoietic target genes.

Authors:  Rachit Bakshi; Mohammad Q Hassan; Jitesh Pratap; Jane B Lian; Martin A Montecino; Andre J van Wijnen; Janet L Stein; Anthony N Imbalzano; Gary S Stein
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

2.  Ikaros limits basophil development by suppressing C/EBP-α expression.

Authors:  Kavitha N Rao; Craig Smuda; Gregory D Gregory; Booki Min; Melissa A Brown
Journal:  Blood       Date:  2013-08-29       Impact factor: 22.113

3.  Deciding the decider: Mef2c in hematopoiesis.

Authors:  Rachel M Gerstein
Journal:  Nat Immunol       Date:  2009-03       Impact factor: 25.606

4.  The role of the chromatin remodeler Mi-2beta in hematopoietic stem cell self-renewal and multilineage differentiation.

Authors:  Toshimi Yoshida; Idit Hazan; Jiangwen Zhang; Samuel Y Ng; Taku Naito; Hugo J Snippert; Elizabeth J Heller; Xiaoqing Qi; Lee N Lawton; Christine J Williams; Katia Georgopoulos
Journal:  Genes Dev       Date:  2008-05-01       Impact factor: 11.361

5.  Ikaros promotes early-born neuronal fates in the cerebral cortex.

Authors:  Jessica M Alsiö; Basile Tarchini; Michel Cayouette; Frederick J Livesey
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

6.  FOG-1-mediated recruitment of NuRD is required for cell lineage re-enforcement during haematopoiesis.

Authors:  Zhiguang Gao; Zan Huang; Harold E Olivey; Sandeep Gurbuxani; John D Crispino; Eric C Svensson
Journal:  EMBO J       Date:  2009-12-10       Impact factor: 11.598

7.  Human gamma-satellite DNA maintains open chromatin structure and protects a transgene from epigenetic silencing.

Authors:  Jung-Hyun Kim; Thomas Ebersole; Natalay Kouprina; Vladimir N Noskov; Jun-Ichirou Ohzeki; Hiroshi Masumoto; Brankica Mravinac; Beth A Sullivan; Adam Pavlicek; Sinisa Dovat; Svetlana D Pack; Yoo-Wook Kwon; Patrick T Flanagan; Dmitri Loukinov; Victor Lobanenkov; Vladimir Larionov
Journal:  Genome Res       Date:  2009-01-13       Impact factor: 9.043

Review 8.  Competition and collaboration: GATA-3, PU.1, and Notch signaling in early T-cell fate determination.

Authors:  Ellen V Rothenberg; Deirdre D Scripture-Adams
Journal:  Semin Immunol       Date:  2008-09-03       Impact factor: 11.130

9.  Characterization of the histone H2A.Z-1 and H2A.Z-2 isoforms in vertebrates.

Authors:  Deanna Dryhurst; Toyotaka Ishibashi; Kristie L Rose; José M Eirín-López; Darin McDonald; Begonia Silva-Moreno; Nik Veldhoen; Caren C Helbing; Michael J Hendzel; Jeffrey Shabanowitz; Donald F Hunt; Juan Ausió
Journal:  BMC Biol       Date:  2009-12-14       Impact factor: 7.431

10.  Molecular signatures of quiescent, mobilized and leukemia-initiating hematopoietic stem cells.

Authors:  E Camilla Forsberg; Emmanuelle Passegué; Susan S Prohaska; Amy J Wagers; Martina Koeva; Joshua M Stuart; Irving L Weissman
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.